Your session is about to expire
← Back to Search
Music Therapy for Alzheimer's Disease
N/A
Recruiting
Led By Joanne Loewy, DA, LCAT, MT-BC
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of Alzheimer's disease or mild cognitive impairment
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial will compare the effects of music therapy experiences on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment.
Eligible Conditions
- Alzheimer's Disease
- Mild Cognitive Impairment
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You have been diagnosed with Alzheimer's disease or mild cognitive impairment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Activities of Daily Living (ADCS-ADL)
Clinician's Global Impression of Change (ADCS-CGIC)
Mini Mental Status Exam (MMSE)
+1 moreSecondary outcome measures
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog)
Zarit Burden Interview
Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Home-based MT through Supervised, Supported Singing (H3S)Experimental Treatment1 Intervention
Treatment arm 1
Group II: H3S and IMTExperimental Treatment2 Interventions
Treatment arm 2 received both Home-based Supervised, Supported Singing (H3S) and Individualized Music Therapy (IMT)
Group III: Attention Control (AtCon)Placebo Group1 Intervention
Comparison condition with comparable attention
Find a Location
Who is running the clinical trial?
Icahn School of Medicine at Mount SinaiLead Sponsor
850 Previous Clinical Trials
535,734 Total Patients Enrolled
Joanne Loewy, DA, LCAT, MT-BCPrincipal InvestigatorMount Sinai Beth Israel
1 Previous Clinical Trials
178 Total Patients Enrolled
Mary Sano, PhDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
5 Previous Clinical Trials
1,221 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been diagnosed with Alzheimer's disease or mild cognitive impairment.Likely Alzheimer's disease in someone with Down syndrome.You have had a major stroke that caused lasting problems.You have had epilepsy, a specific type of brain problem, or a head injury within the past two years.You have other health conditions that make it difficult for you to participate in the study, such as significant pain or a life expectancy of less than 1 year.You have been diagnosed with Alzheimer's disease or mild cognitive impairment.You have been diagnosed with a type of dementia other than Alzheimer's disease.You have a serious mental health condition like schizophrenia, severe depression, bipolar disorder, or struggles with alcohol or drug abuse.
Research Study Groups:
This trial has the following groups:- Group 1: Home-based MT through Supervised, Supported Singing (H3S)
- Group 2: H3S and IMT
- Group 3: Attention Control (AtCon)
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings to participate in the trial at this time?
"Clinicaltrials.gov lists this trial as currently recruiting participants, with a posting date of July 25th 2019 and an edit on December 7th 2020."
Answered by AI
How many participants have enrolled in this research initiative?
"Affirmative. The information hosted on clinicaltrials.gov specifies that this medical experiment is presently bringing in patients; it was first posted on July 25th 2019 and its details were recently updated on December 7th 2020. One hundred participants are needed between two locations for the trial to be complete."
Answered by AI
Who else is applying?
What site did they apply to?
Louis Armstrong Center for Music and Medicine, Mount Sinai Beth Israel
What portion of applicants met pre-screening criteria?
Met criteria
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How long will screening last?
PatientReceived no prior treatments
Share this study with friends
Copy Link
Messenger